2. UroToday Home
  3. Video Lectures

Renal Cancer Videos

Smoking Cessation as a Precision Cancer Care Intervention in Urologic Oncology - Richard Matulewicz
January 31, 2025
Details
AI in Renal Mass Classification: Current Challenges and Future Potential - Nicholas Kavoussi
January 29, 2025
Details
The Value and Limitations of Biopsies for Small Renal Masses - Phillip Pierorazio
January 21, 2025
Details
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis - Beyond the Abstract
January 14, 2025
Details
Outcomes with Novel Combinations in Non-Clear Cell RCC: ORACLE Study - Deepak Kilari
January 9, 2025
Details
Microbiome Manipulation in the Treatment of Kidney Cancer - Monty Pal
January 6, 2025
Details
Advancing Imaging Techniques for Small Renal Mass Diagnosis and Clinical Decision-Making - Sam Chang
December 30, 2024
Details
Research Maps Renal Cancer Transcription Signatures - Pedro Barata
November 7, 2024
Details
Innovative Therapies in GU Cancers: Promising Targets in Urothelial and Kidney Cancer - Jonathan Rosenberg
November 7, 2024
Details
Oligometastatic vs Oligoprogressive RCC Treatment Strategies - Chad Tang
October 7, 2024
Details
Highlights in Non-Prostate GU Oncology from ESMO 2024 - Ignacio Duran
October 4, 2024
Details
Glycoproteomics in Kidney Cancer: CheckMate 9ER Biomarker Analysis - David Braun
September 23, 2024
Details
CaboPoint Trial: Cabozantinib in Second-Line RCC Treatment - Laurence Albiges
September 19, 2024
Details
Fecal Microbiota Transplant Boosts Immunotherapy in Metastatic Renal Cell Carcinoma in TACITO-II Trial - Chiara Ciccarese
September 15, 2024
Details
HIF-2 Alpha Inhibitor NKT2152 Shows Impact in Renal Cell Carcinoma - Eric Jonasch
September 13, 2024
Details
GPT-4 in Urology: Revolutionizing Renal Surgery Data Extraction - Jessica Hsueh & Mark Ball
August 26, 2024
Details
Advancing Radiopharmaceuticals: Targeting Strategies and Isotope Selection in Cancer Therapy - John Babich
August 9, 2024
Details
Advancing RCC Treatment: PROSPER Trial Analysis and Future Directions - Naomi Haas
August 7, 2024
Details
Understanding KEYNOTE-564: Pembrolizumab’s Role and Post-Adjuvant Therapy for RCC Patients - Karl Semaan & Talal El Zarif
June 26, 2024
Details
Functional Renal Imaging and Advances in Kidney Cancer Detection - Shankar Siva
June 24, 2024
Details
Update on Biomarkers in Renal Cell Carcinoma - David Braun
February 29, 2024
Details
KEYNOTE-564 Shows Overall Survival Benefit in Kidney Cancer with Pembrolizumab - Toni Choueiri
February 21, 2024
Details
Socioeconomic Disparities Drive Alarming Racial Gaps in Kidney Cancer Patient Survival Rates - Nirmish Singla
December 11, 2023
Details
Addressing the Gaps in Quality of Life: A New Measure for Renal Cell Carcinoma Patients - Cristiane Bergerot
June 15, 2023
Details
Enhancing Patient-Centered Communication in Small Renal Mass Management - Kathryn Hacker Gessner
June 2, 2023
Details
Advancing Treatment for Non-Clear Renal Cell Carcinoma: Insights and Future Directions (PAPMET & PAPMET 2) - Benjamin Maughan
May 15, 2023
Details
Brain Metastases From Renal Cell Carcinoma Treated With First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium - Kosuke Takemura
March 23, 2023
Details
Results from the Phase 3 Study of 89Zr-DFO-Girentuximab for PET/CT Imaging of Clear Cell Renal Cell Carcinoma (ZIRCON) - Brian Shuch
February 24, 2023
Details
Fueling Wellness with Flavor for Cancer Patients: The Wellness Principles - Gary Deng
January 30, 2023
Details
The Role of Everolimus in the Adjuvant Setting for Patients with Renal Cell Carcinoma: EVEREST (SWOG S0931) - Christopher Ryan
January 25, 2023
Details
The ORACLE Study: The Efficacy of Combination Systemic Therapies in Patients with Non-Clear Cell Renal Cell Carcinoma - Deepak Kilari
January 3, 2023
Details
Atezolizumab as Adjuvant Therapy After Resection for Patients with Renal Cell Carcinoma with Increased Risk of Recurrence: IMmotion010 Trial, Journal Club - Zachary Klaassen
December 15, 2022
Details
Results of a Phase II Randomized Double Blind Trial of PF-04518600, OX40 Antibody, in Combination with Axitinib - Sarmad Sadeghi
October 17, 2022
Details
Pembrolizumab in Combination with Lenvatinib as First-Line Treatment for Non Clear Cell Renal Cell Carcinoma (nccRCC), KEYNOTE-B61 - Laurence Albiges
September 22, 2022
Details
Why Not Biopsy? Challenging the Status Quo in Renal Mass Management - Jaime Landman
June 21, 2022
Details
How Office-Based Renal Biopsies Could Upend Current Urological Guidelines - Jaime Landman
August 26, 2021
Details
Superfluous Hospital Expenditure Associated with Unnecessary Renal Cyst Surveillance - Lee Ponsky & Laura Bukavina
January 27, 2020
Details
CT Guided Percutaneous Renal Mass Cryoablation - Daniel Watson
December 13, 2019
Details
Supine PCNL (Ambulatory): Who? What? When? Why? How? - James F. Borin
December 13, 2019
Details
Outpatient Renal Procedures - Ashley Baker
December 13, 2019
Details
The Role of Cytoreductive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma - Neeraj Agarwal, MD
June 9, 2019
Details
Advances of Systemic Treatments in Renal Cell Carcinoma - Jens Bedke
April 22, 2019
Details
Office-based, Ultrasound-Guided Renal Mass Biopsy: Technique and Results - Jaime Landman
March 27, 2019
Details
Patient Advocacy and Resources in Kidney Cancer - Dena Battle
February 6, 2019
Details
Treatment Strategies in Kidney Cancer and the Results of CARMENA - Toni Choueiri
November 9, 2018
Details